. 24/7 Space News .
TECH SPACE
Crowdsourced virtual supercomputer revs up virus research
By Rob Lever
Washington (AFP) March 22, 2020

China embarks on clinical trial for virus vaccine
Beijing (AFP) March 22, 2020 - China has started the first phase of a clinical trial for a novel coronavirus vaccine, records show, as the world's scientists race to find a way to combat the deadly pathogen.

It comes after US health officials said last week they had started a trial to evaluate a possible vaccine in Seattle.

The Chinese effort began on March 16 -- the same day as the US announcement -- and is expected to continue until the end of the year, according to a filing in the country's Clinical Trial Registry, dated March 17.

"Volunteers of the COVID-19 phase one trial have already started receiving the vaccine," a staff member involved in the government-funded project told AFP on Sunday.

The 108 participants, aged between 18 and 60, will be tested in three groups and given different dosages. They are all residents of the central city of Wuhan -- where the new coronavirus first emerged late last year.

As the COVID-19 pandemic rages and governments step up protection measures, pharmaceutical companies and research labs around the world are working at full tilt.

There are currently no approved vaccines or medication for the new disease, which has killed more than 13,000 people worldwide so far.

The vaccine trial announcements come amid an escalating feud between the US and China over the pandemic, with President Donald Trump enraging Beijing by speaking of the "Chinese virus".

China's nationalistic Global Times published an opinion piece last week noting "the development of a vaccine is a battle that China cannot afford to lose".

But the quest is expected to take time -- the US candidate vaccine may take another year to 18 months before becoming available.

An antiviral treatment called remdesivir, made by US-based Gilead Sciences, is already in the final stages of clinical trials in Asia and doctors in China have reported it has proven effective in fighting the disease.

But only randomised trials will allow scientists to know for sure if it really helps or whether patients would have recovered without it.

Gamers, bitcoin "miners" and companies large and small have teamed up for an unprecedented data-crunching effort that aims to harness idle computing power to accelerate research for a coronavirus treatment.

The project led by computational biologists has effectively created the world's most powerful supercomputer that can handle trillions of calculations needed to understand the structure of the virus.

More than 400,000 users downloaded the application in the past two weeks from "Folding@Home," according to director Greg Bowman, a professor of biochemistry and molecular biophysics at Washington University in St. Louis, where the project is based.

The "distributed computing" effort ties together thousands of devices to create a virtual supercomputer.

The project originally launched at Stanford University 20 years ago was designed to use crowdsourced computing power for simulations to better understand diseases, especially "protein folding" anomalies that can make pathogens deadly.

"The simulations allow us to watch how every atom moves throughout time," Bowman told AFP.

The massive analysis looks for "pockets" or holes in the virus where a drug can be squeezed in.

"Our primary objective is to hunt for binding sites for therapeutics," Bowman said.

- 'Druggable targets' -

The powerful computing effort can test potential drug therapies, a technique known as computational drug design.

Bowman said he is optimistic about this effort because the team previously found a "druggable" target in the Ebola virus and because COVID-19 is structurally similar to the SARS virus which has been the subject of many studies.

"The best opportunity for the near-term future is if we can find an existing drug that can bind to one of these sites," he said.

"If that happens it could be used right away."

This is likely to include drugs like the antimalarials chloroquine and hydroxychloroquine which may be "repurposed" for COVID-19.

Bowman said the project has been able to boost its power to some 400 petaflops -- with each petaflop having a capacity to carry out one quadrillion calculations per second -- or three times more powerful than the world's top supercomputers.

Other supercomputers are also working in parallel. The Oak Ridge National Laboratory said earlier this month that by using IBM's most powerful supercomputer it had identified 77 potential compounds that could bind to the main "spike" protein of the coronavirus to disarm the pathogen.

- 'No end' to compute power -

The Folding@Home project is fueled by crowdsourced computing power from people's desktops, laptops and even PlayStation consoles, as well as more powerful business computers and servers.

"There is no end to the compute power than we can use in principle," Bowman said. Large tech firms including Microsoft-owned GitHub are also participating, and the project is in discussions with others.

Anyone with a relatively recent computer can contribute by installing a program which downloads a small amount of data for analysis. People can choose which disease they wish to work on.

"It's like bitcoin mining, but in the service of humanity," said Quentin Rhoads-Herrera of the security firm Critical Start, which has provided its powerful password "hash cracker" computer designed to decrypt passwords to the project.

Rhoads-Herrera said his team of security researchers, sometimes described as "white hat hackers," were encouraging more people to get involved.

- Fighting helplessness -

Computer chipmaker Nvidia, which makes powerful graphics processors for gaming devices, called on gamers to join the effort as well.

"The response has been record-breaking, with tens of thousands of new users," joining, said Nvidia spokesman Hector Marinez.

One of the largest contributions comes from a Reddit group of PC enthusiasts and gamers which has some 24,000 members participating.

"It is a fantastic weapon against the feeling of helplessness," said Pedro Valadas, a lawyer in Portugal who heads the Reddit community and is a part of the project's advisory board.

"The fact that anyone, at home, with a computer, can play a role and help fight against (disease) for the common good is a powerful statement," Valadas told AFP.


Related Links
Space Technology News - Applications and Research


Thanks for being there;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Monthly Supporter
$5+ Billed Monthly


paypal only
SpaceDaily Contributor
$5 Billed Once


credit card or paypal


TECH SPACE
Time-resolved measurement in a memory device
Zurich, Switzerland (SPX) Feb 24, 2020
At the Department for Materials of the ETH in Zurich, Pietro Gambardella and his collaborators investigate tomorrow's memory devices. They should be fast, retain data reliably for a long time and also be cheap. So-called magnetic "random access memories" (MRAM) achieve this quadrature of the circle by combining fast switching via electric currents with durable data storage in magnetic materials. A few years ago researchers could already show that a certain physical effect - the spin-orbit torque - ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

TECH SPACE
How Space Station research is helping NASA's plans to explore the Moon and Beyond

Mission Control adjusts to coronavirus conditions

Insects, seaweed and lab-grown meat could be the foods of the future

Science takes time, even in a lab moving 17,500 miles per hour

TECH SPACE
SpaceX plans first manned flight to space station in May

NASA's mobile moon rocket tower 44% over budget, IG says

NASA, SpaceX plan return to human spaceflight from U.S. soil in mid-May

Spacex Falcon 9 launches sixth batch of Starlink satellites

TECH SPACE
NASA's Mars Perseverance Rover Gets Its Sample Handling System

Waves in thin Martian air with wide effects

ExoMars to take off for the Red Planet in 2022

Europe-Russia delay mission to find life on Mars

TECH SPACE
China's Long March-7A carrier rocket fails in maiden flight

China's Yuanwang-5 sails to Pacific Ocean for space monitoring mission

Construction of China's space station begins with start of LM-5B launch campaign

China Prepares to Launch Unknown Satellite Aboard Long March 7A Rocket

TECH SPACE
Soyuz to launch another batch of OneWeb constellation satellites

SpaceX launches Starlink mission from Florida

NewSpace Book on 10 Years of Commercial Space and Children's Book on Space Released

GMV's space business grows by 30 percent

TECH SPACE
Europlanet launches 10 million euro research infrastructure supporting planetary science

Raytheon completes first tests of radar for anti-hypersonic sensor

L3Harris Technologies introduces new reflector antenna tailored for smallsat missions

Brussels calling: Can the EU be run by videolink

TECH SPACE
The Strange Orbits of 'Tatooine' Planetary Disks

Salmon parasite is world's first non-oxygen breathing animal

Observed: An exoplanet where it rains iron

Scientists have discovered the origins of the building blocks of life

TECH SPACE
Jupiter's Great Red Spot shrinking in size, not thickness

Researchers find new minor planets beyond Neptune

Ultraviolet instrument delivered for ESA's Jupiter mission

One Step Closer to the Edge of the Solar System









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.